Overexpression of circ_0001445 decelerates hepatocellular carcinoma progression by regulating miR-942-5p/ALX4 axis

Qinhong Xu1, Lijing Zhou1, Ganghua Yang1

  • 1Department of Geriatric Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277, Yanta West Road, Xi'an, 710061, Shaanxi, China.

Biotechnology Letters
|August 29, 2020
PubMed

Insights

Circular RNAs (circRNAs) regulate hepatocellular carcinoma (HCC). This study shows circ_0001445 inhibits HCC progression by targeting the miR-942-5p/ALX4 pathway, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are crucial in human cancer development.
  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • The specific role of circ_0001445 in HCC remains largely unexplored.

Purpose of the Study:

  • To investigate the function and mechanism of circ_0001445 in hepatocellular carcinoma.
  • To elucidate the regulatory relationship between circ_0001445, miR-942-5p, and ALX4 in HCC.

Main Methods:

  • Quantitative real-time PCR to measure circRNA and miRNA expression.
  • Cell-based assays to assess proliferation, migration, invasion, and epithelial-mesenchymal transition.
  • In vivo tumor xenograft models to evaluate tumorigenesis.
  • Bioinformatic analysis and molecular experiments to confirm targeting interactions.

Main Results:

  • circ_0001445 expression was significantly downregulated in HCC tissues and cells.
  • Overexpression of circ_0001445 or inhibition of miR-942-5p suppressed HCC cell proliferation, migration, invasion, EMT, and glycolysis.
  • circ_0001445 acts as a sponge for miR-942-5p, thereby increasing ALX4 expression.
  • miR-942-5p overexpression or ALX4 knockdown reversed the inhibitory effects of circ_0001445.
  • circ_0001445 overexpression inhibited HCC tumorigenesis in vivo.

Conclusions:

  • circ_0001445 functions as a tumor suppressor in HCC by regulating the miR-942-5p/ALX4 axis.
  • circ_0001445 may serve as a novel diagnostic biomarker and therapeutic target for HCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K